Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

This image is advertising the BIA webinar titled, Women in Biotech - Transatlantic. The image has a black background with small orange circles connected by thin orange lines. The BIA logo is included in the image.

Join BIA for the inaugural transatlantic Women in Biotech - extend your networks globally, catch up with familiar faces, and help us to make a difference. 

Whilst VCs in life sciences continue to put management teams that are ‘proven’ or known to them in place rather than backing diverse ones, later investment rounds will demand a broader, more diverse set of thinking to which companies need to adapt in order to attract more mature capital.

You'll discuss these challenges with a panel representing a range of different investment stages – from both investor and leadership perspectives - taking in points of view from both sides of the Atlantic and encouraging an interactive discussion around best practice and how we can affect change, asking “how do we encourage investors to back female-led/founded companies and diverse leadership teams from company inception?”.

Click here to register

With their charity partner of the year, Ovarian Cancer Action, BIA is supporting Ovarian Cancer Awareness month at this Women in Biotech event. Cary Wakefield, CEO of Ovarian Cancer Action, will join to give a few words at the start of the event. Additionally, BIA will be donating £10 per ticket sold for the event to Ovarian Cancer Action.